Federated Hermes, Inc. Harmony Biosciences Holdings, Inc. Transaction History
Federated Hermes, Inc.
- $50.2 Billion
- Q2 2025
A detailed history of Federated Hermes, Inc. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 293,842 shares of HRMY stock, worth $9.55 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
293,842
Previous 439,884
33.2%
Holding current value
$9.55 Million
Previous $14.6 Million
36.4%
% of portfolio
0.02%
Previous 0.03%
Shares
14 transactions
Others Institutions Holding HRMY
# of Institutions
289Shares Held
46.3MCall Options Held
316KPut Options Held
69.9K-
Valor Management LLC Chicago, IL6.62MShares$215 Million88.32% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$190 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$166 Million0.0% of portfolio
-
State Street Corp Boston, MA1.63MShares$53 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.58MShares$51.4 Million0.01% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.92B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...